Volcano Adds CardioSpectra High-Res Imaging To Intravascular Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Intravascular imaging firm Volcano hopes to have an application before FDA for optical coherence tomography sometime next year after inking a deal worth up to $63 million to acquire the technology developer CardioSpectra